EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW)

CUSIP: G3141W122

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / *W EXP 10/23/202
Total 13F shares
1,364,106
Share change
-98,917
Total reported value
$52,333
Price per share
$0.04
Number of holders
19
Value change
-$6,820
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP G3141W122?
CUSIP G3141W122 identifies EUCRW - EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) as of Q1 2023

As of 31 Mar 2023, EUCRATES BIOMEDICAL ACQU COR - *W EXP 10/23/202 (EUCRW) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,364,106 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), COWEN AND COMPANY, LLC, 683 Capital Management, LLC, Altium Capital Management LP, Arena Investors LP, KINGDON CAPITAL MANAGEMENT, L.L.C., RIVERNORTH CAPITAL MANAGEMENT, LLC, AQR Arbitrage LLC, K2 PRINCIPAL FUND, L.P., and Cowen Investment Management LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.